✦ LIBER ✦

MRSA admission screening not cost effective in the UK

✍ Scribed by Spyns, Peter; D’Halleweyn, Elisabeth

Book ID: 121634375
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 128 KB
Volume: 679
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-013-0421-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of universal MRSA scr

Cost-effectiveness of universal MRSA screening on admission to surgery

✍ A. Murthy; G. De Angelis; D. Pittet; J. Schrenzel; I. Uckay; S. Harbarth 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Evidence for cost reduction based on pre

Evidence for cost reduction based on pre-admission MRSA screening in general surgery

✍ Ricarda Diller; Anne K. Sonntag; Alexander Mellmann; Knut Grevener; Norbert Senn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 German ⚖ 211 KB

Cost-effectiveness of rapid MRSA screeni

Cost-effectiveness of rapid MRSA screening in surgical patients

✍ Marten Schulz; Claudia Nonnenmacher; Reinier Mutters 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 119 KB

Universal pneumococcal vax in UK infants

Universal pneumococcal vax in UK infants not cost effective

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Hepatocellular carcinoma screening in pe

Hepatocellular carcinoma screening in people with liver cirrhosis is not cost-effective

✍ Dirk Uhlmann; Helmut Witzigmann 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Mifamurtide cost effective for osteosarc

Mifamurtide cost effective for osteosarcoma in the UK

✍ Yu, Xingwang; Peng, Hui; Liu, Yanmin; Zhang, Yan; Shu, Yingjie; Chen, Quanjia; S 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB